Quick Answer
HOOKIPA Pharma Inc. reported Net Income Loss of -$43.50 million for the year ending 2024.
- HOOKIPA Pharma Inc. showed an increase of +46.7% in Net Income Loss from 2023 to 2024.
- This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2017 to 2024), HOOKIPA Pharma Inc.'s Net Income Loss has declined by 241.9%.
- Historical annual values: Fiscal year 2024: -$43.50 million | Fiscal year 2023: -$81.58 million | Fiscal year 2022: -$64.92 million | Fiscal year 2021: -$75.67 million | Fiscal year 2020: -$44.08 million | Fiscal year 2019: -$43.04 million | Fiscal year 2018: -$16.24 million | Fiscal year 2017: -$12.72 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: